Financial statements Ars-Medicabis
Balance sheet data of ARS-MEDICABIS
|
Year
|
2018
|
2019
|
2020
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 249 296,70 | 232 726,78 | 239 597,18 | 279 886,37 | 276 561,60 |
| A. Fixed assets | 67 323,17 | 66 695,12 | 96 049,07 | 215 657,54 | 166 986,84 |
| B. Current assets | 181 973,53 | 166 031,66 | 143 548,11 | 64 228,83 | 109 574,76 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - |
| Total liabilities | 249 296,70 | 232 726,78 | 239 597,18 | 279 886,37 | 276 561,60 |
| A. Equity | 13 642,97 | 63 300,95 | 209 284,27 | 266 553,04 | 177 039,76 |
| B. Liabilities and provisions for liabilities | 235 653,73 | 169 425,83 | 30 312,91 | 13 333,33 | 99 521,84 |
| I. Long-term liabilities | - | 0,00 | - | - | 61 143,54 |
| II. Short-term liabilities | 235 653,73 | 169 425,83 | 30 312,91 | 13 333,33 | 38 378,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.